Anti B-cell maturation antigen CAR T-cell and antibody drug conjugate therapy for heavily pretreated relapsed and refractory multiple myeloma: A summary from the Institute for Clinical and Economic Review’s Midwest Comparative Effectiveness Public Advisory Council

Detalles Bibliográficos
Autores principales: Beinfeld, Molly, Lee, Sei, McQueen, Brett, Fluetsch, Noemi, Pearson, Steven D, Ollendorf, Daniel A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2021
Materias:
Perspectives on Value
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391002/
https://www.ncbi.nlm.nih.gov/pubmed/34464215
http://dx.doi.org/10.18553/jmcp.2021.27.9.1315
_version_ 1785082602715086848
author Beinfeld, Molly
Lee, Sei
McQueen, Brett
Fluetsch, Noemi
Pearson, Steven D
Ollendorf, Daniel A
author_facet Beinfeld, Molly
Lee, Sei
McQueen, Brett
Fluetsch, Noemi
Pearson, Steven D
Ollendorf, Daniel A
author_sort Beinfeld, Molly
collection PubMed
description
format Online
Article
Text
id pubmed-10391002
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Academy of Managed Care Pharmacy
record_format MEDLINE/PubMed
spelling pubmed-103910022023-08-02 Anti B-cell maturation antigen CAR T-cell and antibody drug conjugate therapy for heavily pretreated relapsed and refractory multiple myeloma: A summary from the Institute for Clinical and Economic Review’s Midwest Comparative Effectiveness Public Advisory Council Beinfeld, Molly Lee, Sei McQueen, Brett Fluetsch, Noemi Pearson, Steven D Ollendorf, Daniel A J Manag Care Spec Pharm Perspectives on Value Academy of Managed Care Pharmacy 2021-09 /pmc/articles/PMC10391002/ /pubmed/34464215 http://dx.doi.org/10.18553/jmcp.2021.27.9.1315 Text en Copyright © 2021, Academy of Managed Care Pharmacy. All rights reserved. https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Perspectives on Value
Beinfeld, Molly
Lee, Sei
McQueen, Brett
Fluetsch, Noemi
Pearson, Steven D
Ollendorf, Daniel A
Anti B-cell maturation antigen CAR T-cell and antibody drug conjugate therapy for heavily pretreated relapsed and refractory multiple myeloma: A summary from the Institute for Clinical and Economic Review’s Midwest Comparative Effectiveness Public Advisory Council
title Anti B-cell maturation antigen CAR T-cell and antibody drug conjugate therapy for heavily pretreated relapsed and refractory multiple myeloma: A summary from the Institute for Clinical and Economic Review’s Midwest Comparative Effectiveness Public Advisory Council
title_full Anti B-cell maturation antigen CAR T-cell and antibody drug conjugate therapy for heavily pretreated relapsed and refractory multiple myeloma: A summary from the Institute for Clinical and Economic Review’s Midwest Comparative Effectiveness Public Advisory Council
title_fullStr Anti B-cell maturation antigen CAR T-cell and antibody drug conjugate therapy for heavily pretreated relapsed and refractory multiple myeloma: A summary from the Institute for Clinical and Economic Review’s Midwest Comparative Effectiveness Public Advisory Council
title_full_unstemmed Anti B-cell maturation antigen CAR T-cell and antibody drug conjugate therapy for heavily pretreated relapsed and refractory multiple myeloma: A summary from the Institute for Clinical and Economic Review’s Midwest Comparative Effectiveness Public Advisory Council
title_short Anti B-cell maturation antigen CAR T-cell and antibody drug conjugate therapy for heavily pretreated relapsed and refractory multiple myeloma: A summary from the Institute for Clinical and Economic Review’s Midwest Comparative Effectiveness Public Advisory Council
title_sort anti b-cell maturation antigen car t-cell and antibody drug conjugate therapy for heavily pretreated relapsed and refractory multiple myeloma: a summary from the institute for clinical and economic review’s midwest comparative effectiveness public advisory council
topic Perspectives on Value
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391002/
https://www.ncbi.nlm.nih.gov/pubmed/34464215
http://dx.doi.org/10.18553/jmcp.2021.27.9.1315
work_keys_str_mv AT beinfeldmolly antibcellmaturationantigencartcellandantibodydrugconjugatetherapyforheavilypretreatedrelapsedandrefractorymultiplemyelomaasummaryfromtheinstituteforclinicalandeconomicreviewsmidwestcomparativeeffectivenesspublicadvisorycouncil
AT leesei antibcellmaturationantigencartcellandantibodydrugconjugatetherapyforheavilypretreatedrelapsedandrefractorymultiplemyelomaasummaryfromtheinstituteforclinicalandeconomicreviewsmidwestcomparativeeffectivenesspublicadvisorycouncil
AT mcqueenbrett antibcellmaturationantigencartcellandantibodydrugconjugatetherapyforheavilypretreatedrelapsedandrefractorymultiplemyelomaasummaryfromtheinstituteforclinicalandeconomicreviewsmidwestcomparativeeffectivenesspublicadvisorycouncil
AT fluetschnoemi antibcellmaturationantigencartcellandantibodydrugconjugatetherapyforheavilypretreatedrelapsedandrefractorymultiplemyelomaasummaryfromtheinstituteforclinicalandeconomicreviewsmidwestcomparativeeffectivenesspublicadvisorycouncil
AT pearsonstevend antibcellmaturationantigencartcellandantibodydrugconjugatetherapyforheavilypretreatedrelapsedandrefractorymultiplemyelomaasummaryfromtheinstituteforclinicalandeconomicreviewsmidwestcomparativeeffectivenesspublicadvisorycouncil
AT ollendorfdaniela antibcellmaturationantigencartcellandantibodydrugconjugatetherapyforheavilypretreatedrelapsedandrefractorymultiplemyelomaasummaryfromtheinstituteforclinicalandeconomicreviewsmidwestcomparativeeffectivenesspublicadvisorycouncil

Ejemplares similares